Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF testing for multiple sclerosis

Michael P Pender

    The Lancet. Neurology
    |August 20, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis.

    Multiple sclerosis journal - experimental, translational and clinical·2021
    Same author

    Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.

    Frontiers in neurology·2021
    Same author

    Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020).

    Trends in molecular medicine·2021
    Same author

    Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

    JCI insight·2020
    Same author

    Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types.

    Frontiers in immunology·2020
    Same author

    Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis-A Possible Cause of Constitutive NF-κB Activation.

    Journal of clinical medicine·2020
    Same journal

    Resolution of expression of concern-Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

    The Lancet. Neurology·2026
    Same journal

    UCL Queen Square Institute of Neurology: 75 years of innovation.

    The Lancet. Neurology·2026
    Same journal

    Correction to Lancet Neurol 2026; 25: 631.

    The Lancet. Neurology·2026
    Same journal

    Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.

    The Lancet. Neurology·2026
    Same journal

    Correction to Lancet Neurol 2025; 24: 740-52.

    The Lancet. Neurology·2026
    Same journal

    Correction to Lancet Neurol 2026; 25: 357-67.

    The Lancet. Neurology·2026
    See all related articles